These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23142264)

  • 1. Understanding risk factors for Alzheimer's disease: interplay of neuroinflammation, connexin-based communication and oxidative stress.
    Quintanilla RA; Orellana JA; von Bernhardi R
    Arch Med Res; 2012 Nov; 43(8):632-44. PubMed ID: 23142264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial connexin expression and function in the context of Alzheimer's disease.
    Koulakoff A; Mei X; Orellana JA; Sáez JC; Giaume C
    Biochim Biophys Acta; 2012 Aug; 1818(8):2048-57. PubMed ID: 22008509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glial hemichannels by boldine treatment reduces neuronal suffering in a murine model of Alzheimer's disease.
    Yi C; Ezan P; Fernández P; Schmitt J; Sáez JC; Giaume C; Koulakoff A
    Glia; 2017 Oct; 65(10):1607-1625. PubMed ID: 28703353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease.
    Yi C; Koulakoff A; Giaume C
    Curr Pharm Des; 2017; 23(33):4958-4968. PubMed ID: 28982320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's pathogenesis and its link to the mitochondrion.
    Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
    Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.
    von Bernhardi R; Eugenín J
    Antioxid Redox Signal; 2012 May; 16(9):974-1031. PubMed ID: 22122400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
    Agostinho P; Cunha RA; Oliveira C
    Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease.
    Yi C; Mei X; Ezan P; Mato S; Matias I; Giaume C; Koulakoff A
    Cell Death Differ; 2016 Oct; 23(10):1691-701. PubMed ID: 27391799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexins and pannexins in Alzheimer's disease.
    Giaume C; Sáez JC; Song W; Leybaert L; Naus CC
    Neurosci Lett; 2019 Mar; 695():100-105. PubMed ID: 28893592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cell dysregulation: a new perspective on Alzheimer disease.
    von Bernhardi R
    Neurotox Res; 2007 Dec; 12(4):215-32. PubMed ID: 18201950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    Adiele RC; Adiele CA
    J Alzheimers Dis; 2016 Jul; 53(4):1257-70. PubMed ID: 27392851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.
    Kim E; Otgontenger U; Jamsranjav A; Kim SS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.